AR098790A1 - Terapia combinada con un anticuerpo anti-ang2 y un agonista de cd40 - Google Patents

Terapia combinada con un anticuerpo anti-ang2 y un agonista de cd40

Info

Publication number
AR098790A1
AR098790A1 ARP140104710A ARP140104710A AR098790A1 AR 098790 A1 AR098790 A1 AR 098790A1 AR P140104710 A ARP140104710 A AR P140104710A AR P140104710 A ARP140104710 A AR P140104710A AR 098790 A1 AR098790 A1 AR 098790A1
Authority
AR
Argentina
Prior art keywords
agonist
combined therapy
ang2 antibody
antibody
ang2
Prior art date
Application number
ARP140104710A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR098790A1 publication Critical patent/AR098790A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ARP140104710A 2013-12-20 2014-12-17 Terapia combinada con un anticuerpo anti-ang2 y un agonista de cd40 AR098790A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13198753 2013-12-20

Publications (1)

Publication Number Publication Date
AR098790A1 true AR098790A1 (es) 2016-06-15

Family

ID=49876441

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140104710A AR098790A1 (es) 2013-12-20 2014-12-17 Terapia combinada con un anticuerpo anti-ang2 y un agonista de cd40

Country Status (2)

Country Link
AR (1) AR098790A1 (fr)
MA (1) MA39074B1 (fr)

Also Published As

Publication number Publication date
MA39074B1 (fr) 2019-10-31
MA39074A1 (fr) 2018-07-31

Similar Documents

Publication Publication Date Title
CR20160199A (es) Terapia combinada con un anticuerpo anti-ang2 y un agonista de cd40
AR094403A1 (es) Terapia de combinación de anticuerpos anti-her3
CO2018000882A2 (es) Constructos de anticuerpo para flt3 y cd3
CL2018000270A1 (es) Constructos de anticuerpo para cd70 y cd3.
IL244111A0 (en) Survival benefit in patients with solid tumors with elevated c-reactive protein levels
CL2016000460A1 (es) Proteínas de unión al antígeno gitr
CL2015002743A1 (es) Proteínas de unión especificas duales dirigidas contra tnfa
MX2015015970A (es) Anticuerpos receptores de antitransferina y metodos de uso.
MX2018013141A (es) Neurotoxinas quimericas.
GT201700284A (es) Terapias de combinación para enfermedades malignas hematológicas con anticuerpos anti-cd38 e inhibidores de survivina
UY35399A (es) Conjugados de fármacos con anticuerpos
MX375020B (es) Anticuerpos anti-alfa-sinucleina y métodos de uso.
MX2015012326A (es) Anticuerpos anti-crth2 y su uso.
EA201600473A1 (ru) ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА К Tau(PS422) И СПОСОБЫ ПРИМЕНЕНИЯ
BR122019026188A8 (pt) Métodos para determinar se um indivíduo tem doença hepática gordurosa não alcoólica (nafld), se um indivíduo com esteatose não alcoólica tem esteato-hepatite não alcoólica e para monitorar um indivíduo com esteatose não alcoólica para o desenvolvimento de nash
CL2015002724A1 (es) Métodos para tratar la enfermedad de crohn utilizando un anticuerpo anti-il23
MX2018004831A (es) Metodos para confeccionar formas fucosiladas y afucosiladas de una proteina.
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
TWD170386S (zh) 電連接器之部分
TWD167749S (zh) 電連接器
ES2721935T3 (es) Anticuerpos anti-BAG3 para uso terapéutico
LT3060677T (lt) Fermentų tyrimo su dublikuotais fluoroforais būdas
TWD180565S (zh) 塗抹器
MX2016005854A (es) Anticuerpo anti-her3 alosterico de la neuregulina.
TWD166471S (zh) 手錶

Legal Events

Date Code Title Description
FB Suspension of granting procedure